Status:
COMPLETED
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
Lead Sponsor:
Genetesis Inc.
Collaborating Sponsors:
St. John Hospital & Medical Center
Conditions:
Acute Coronary Syndrome
Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
Genetesis is a cardiac diagnostics company which presents a novel magnetocardiogram (MCG) analysis system called CardioFlux. This investigation presents a new, noninvasive diagnostic option to use MCG...
Eligibility Criteria
Inclusion
- Low and intermediate risk ED patients presenting with chest pain of possible cardiac origin who have a negative first troponin result and non-diagnostic ECG that are to be placed in the Cardiac Diagnostic Unit (CDU) for further evaluation.
Exclusion
- ≤ 18 years of age
- Patients unable to fit into device
- Non-ambulatory patients
- Patients with any implantable device or metal in the thorax area (e.g. pacemaker, AICD, bullet fragments in thorax)
- Patients with claustrophobia
- Pregnant women
- Poor candidate for follow-up
- Prisoners
- Repeat participants
Key Trial Info
Start Date :
July 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT03255772
Start Date
July 15 2017
End Date
May 1 2018
Last Update
January 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. John Hospital and Medical Center
Detroit, Michigan, United States, 48236